| Tag | Content |
|---|
EnhancerAtlas ID | HS108-08336 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr11:86221560-86223210 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2A | MA0052.3 | chr11:86222290-86222302 | GCTAAAAATAGA | + | 6.92 | | MEF2B | MA0660.1 | chr11:86222290-86222302 | GCTAAAAATAGA | + | 6.44 | | MEF2C | MA0497.1 | chr11:86222288-86222303 | GTGCTAAAAATAGAA | + | 8.55 | | SOX10 | MA0442.2 | chr11:86221941-86221952 | AAAACAAAGAC | + | 6.14 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_37591 | chr11:86221584-86223511 | HSMMtube |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I086507 | chr11 | 86218775 | 86223056 |
|
Enhancer Sequence | TGGCCAATGA CTCTCAAATA TCTATAGACC AGCGTTTCTC ACCTTTGGCA CTATTGACAT 60
TTTGGGTTGG ATAATTCTTT GCTGTGAGGG GTGTGGTTGT CCTGCACATT GTAGCATGTT 120
TGGCAACATC CTTGGCCTCT ACTTTCCAGA TACCAATAGC ACCTCTCACT ACATTGTGAC 180
AACCAAGAAT ATCTCCAGAC GTTGGCAAAT GTCCCCTGGA GGAAAAAAAT TATCCCTGAT 240
TTTAGAGCCA CTGCACTAGA CCTTTTATTT AACTGCCTAC CTGATATTTC CCTGTGCATA 300
CCTCAAAGGT ACTTCAAACT TAGCATGTAC CAAACCAAAT TTATCATCTA ATCTTCCACC 360
ATTATGACTC AAAGACAAGA AAAAACAAAG ACTCAAGACA AAACTGATTC TCTTTCCTAC 420
TCCCTTTCTC AGTGAATATT TCCCCGACAT AACTAATTTA ACAATTCCAA CCCCTTGAAA 480
TCATCCTTGA TGGTCTCCTC CCTTCTTTTA TACAACCCGT TGCCAAGTTC TTCATTTGTA 540
CTTTCTAAAT AACTCCTGGT TCAAACACTT CTTTCATCAG TAACACTACC TCCTTTATCC 600
ACGCTTCCAA TATCTGTTGC CTGAAGTGCT GCAATAATCT TGTAACATCC ACTCTTGCCT 660
CTCTCCTATT TTCTATATGC TAGTGAGAGT GATGTTCTTG AAATCAATGA CTCATTGTTT 720
TACTTCTTGT GCTAAAAATA GAATAAAGAC CAAAGTCCTC AACACGCCTA CAGAATCTTG 780
TCTGGGTCTT GCCAACTTCC TTACTTCATC TTGTTCCACT CCTCTTCTCA CTCCACACTC 840
TTCAGCCACA CTGGTCTTTT TCCATTCCTT TATGTGCCAT GTTCTTCCTA CTCCAGTGCT 900
ACTTTGAAAC CGCCTTTGCA AAGATTATGA CAGTGAGAGA AATCTAGCAT GGCTGACTTC 960
ATTTTGCTTC TAGTCTCACA GGCTGGCTGT CCTCACTCAT TATTGGGCAG GGCCAGGCTA 1020
ACCATGGGAG GAATTTAGTT TCTAATTTAA CTTTGAAGCA AGTGTGATAA TAGTCTCTCC 1080
ATGAAACTGA TCCCTTCCTT GTTCAGTTTT GGGGGCTGAA ACTGCCTTTG TAAGACTAAG 1140
GAAAGGCCGC AAGATTAGGA TTATGGAAAG GGCCTGACCT CTGCTGAAAT GTAGGCATAG 1200
TTTCTATAAT CCCTTACTGC TCAACAGCCA TGTGGCTCGA GGTCACAAGA TTTTTGACTT 1260
CCCTAGTTGC TCCTGTAGAT AACATCACTA TTGTAGGACC TAAGATTGGT CTTTTGAGAT 1320
GTTTTTCAGA TTTTTGCATT CTGGCAACCA GCTGACCCCA CCAAGACCCA TGACTCATGA 1380
CTCAAATGGT CCTGTGGCCC CTACCTGGAG GTGGACTCAG TGCGCAAGAA CCATTTTCCA 1440
CACTCTTATC ATTTCATCCC CAATCAGCAG TGCCCATTCC CTAGCCTCCT GCCCACCAAA 1500
TTATCCATAA AATCCCTAGC CTCTGAGTTC TCAGGAGGCT AAGCCACTCC CTCCTCTCAG 1560
CTGCCTTGTG TTAATTAAAC CCTTCCTTTA CTGCAATACC ATGGTCTTCG TGAATTGCTT 1620
TTGTCTGTAC AGTGGGCAAG AAGAACCCAT 1650
|
